AGP Picks
View all

Science Press Releases
Provided by AGP

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on October 26, 2026

North Vector Dynamics Closes Series A Exceeding USD $20 Million, One of Canada’s Largest Defence Technology Financings
Oct. 26, 2026

North Vector Dynamics Closes Series A Exceeding USD $20 Million, One of Canada’s Largest Defence Technology Financings

Indeterminate GlobeNewswire
Eikon Therapeutics Presents Updated EIK1001 Data from TeLuRide-005 at the European Society for Medical Oncology Congress
Oct. 26, 2026

Eikon Therapeutics Presents Updated EIK1001 Data from TeLuRide-005 at the European Society for Medical Oncology Congress

Indeterminate GlobeNewswire
BioNTech und DualityBio geben Topline-Ergebnisse der globalen klinischen Phase-3-Studie DYNASTY-Breast02 für Trastuzumab Pamirtecan bei metastasiertem HR+/HER2-low-Brustkrebs bekannt
Oct. 26, 2026

BioNTech und DualityBio geben Topline-Ergebnisse der globalen klinischen Phase-3-Studie DYNASTY-Breast02 für Trastuzumab Pamirtecan bei metastasiertem HR+/HER2-low-Brustkrebs bekannt

Indeterminate GlobeNewswire
BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer
Oct. 26, 2026

BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer

Indeterminate GlobeNewswire
CoinW Partners with EngageLab to Fortify Global Trading Communications
Oct. 26, 2026

CoinW Partners with EngageLab to Fortify Global Trading Communications

Indeterminate GlobeNewswire
HUTCHMED Highlights SANOVO Phase III Data for ORPATHYS® plus TAGRISSO® in First-Line EGFR-Mutated Lung Cancer Presented at ESMO Congress 2026
Oct. 26, 2026

HUTCHMED Highlights SANOVO Phase III Data for ORPATHYS® plus TAGRISSO® in First-Line EGFR-Mutated Lung Cancer Presented at ESMO Congress 2026

Indeterminate GlobeNewswire
Phathom Pharmaceuticals Provides Update on FDA Litigation
Oct. 26, 2026

Phathom Pharmaceuticals Provides Update on FDA Litigation

Indeterminate GlobeNewswire
Li-FT Announces First Results from Summer Drill Program at the Adina-Galinée Lithium Project, Quebec
Oct. 26, 2026

Li-FT Announces First Results from Summer Drill Program at the Adina-Galinée Lithium Project, Quebec

Indeterminate GlobeNewswire
Norsk Hydro: Reminder - Invitation to Hydro’s Investor Day, London
Oct. 26, 2026

Norsk Hydro: Reminder - Invitation to Hydro’s Investor Day, London

Indeterminate GlobeNewswire
Norsk Hydro: Påminnelse - Invitasjon til Hydros investordag i London
Oct. 26, 2026

Norsk Hydro: Påminnelse - Invitasjon til Hydros investordag i London

Indeterminate GlobeNewswire
Microbiotica Presents Phase 1b Clinical Data on MB097 at the European Society for Medical Oncology (ESMO) Congress 2026
Oct. 26, 2026

Microbiotica Presents Phase 1b Clinical Data on MB097 at the European Society for Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire
Barmeter Technologies Issues Statement on Harsha Nooka’s Research on Accessible AI-Generated Web Interfaces
Oct. 26, 2026

Barmeter Technologies Issues Statement on Harsha Nooka’s Research on Accessible AI-Generated Web Interfaces

Indeterminate GlobeNewswire
Barmeter Technologies Issues Statement on Sai Kumar Pola’s Warehouse Robotics Research and API Traffic Management Patent
Oct. 26, 2026

Barmeter Technologies Issues Statement on Sai Kumar Pola’s Warehouse Robotics Research and API Traffic Management Patent

Indeterminate GlobeNewswire
HUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine
Oct. 26, 2026

HUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.